Table 1.
Clinical Characteristics of 155 Patients according to CXCR4 High or Low Expression
| Characteristics | Levels | CXCR4 |
||
|---|---|---|---|---|
| Low (n = 95) | High (n = 60) | p Value | ||
| Age at diagnosis (years), mean ± SD | 66.96 ± 10.35 | 67.72 ± 10.08 | 0.651 | |
| T category, n | 0.888 | |||
| T1 | 50 | 32 | ||
| T2 | 41 | 26 | ||
| T3/T4 | 1 | 0 | ||
| NA | 3 | 2 | ||
| N category, n | 0.004 | |||
| pN0 | 57 | 21 | ||
| pN1 | 26 | 21 | ||
| pN2/pN3 | 8 | 16 | ||
| NA | 4 | 2 | ||
| SBR grade, n | 0.195 | |||
| 1 | 15 | 6 | ||
| 2 | 61 | 33 | ||
| 3 | 16 | 17 | ||
| NA | 3 | 4 | ||
| Adjuvant therapy, n | 0.067 | |||
| TAM | 18 | 16 | ||
| X-ray + TAM | 70 | 44 | ||
| X-ray + TAM + LHRH | 7 | 0 | ||
| Local recurrence/distant metastases, n | <0.001 | |||
| no | 76 | 27 | ||
| yes | 19 | 33 | ||
| Overall death, n | 12 | 30 | <0.001 | |
| Cancer-specific death, n | 9 | 22 | <0.001 | |
LHRH, luteinizing hormone-releasing hormone; NA, not available; SBR, Scarff-Bloom-Richardson; TAM, tamoxifen.